| 04/01/2008 |
Delphi Ventures Recruits MPM Capital and NEA to Lead $65 million TriVascular2 Financing |
| 03/26/2008 |
Breathe Technologies, Inc. Closes on $15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers |
| 03/25/2008 |
Evalve Announces CE Mark Approval of the World’s First Percutaneous Valve Repair System |
| 03/03/2008 |
Alexza’s AZ-104 (Staccato® Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache |
| 02/25/2008 |
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato® Loxapine) |
| 01/28/2008 |
Arbor Surgical Technologies Announces Series C Financing and Licensing Agreement with Medtronic |
| 01/25/2008 |
Phenomix Files Registration Statement for Proposed Initial Public Offering |
| 01/11/2008 |
Alder Biopharmaceuticals Inc. Raises $40 Million in Series C Financing |
| 01/07/2008 |
Aragon Surgical Secures $25 Million in Series B Financing |
| 12/28/2007 |
Alexza Pharmaceuticals, Inc. Announces Partnership with Endo Pharmaceuticals, Inc. |
| 12/04/2007 |
Evalve® Completes $60 Million Series D Financing |
| 10/29/2007 |
Amgen-Ilypsa Spin-out Relypsa Begins Operations with Polymeric Drug Pipeline, Platform and Expert Team in Place |
| 10/17/2007 |
TranS1, Inc. Shares Soar in Market Debut |
| 09/13/2007 |
PTC Therapeutics, Inc. Announces $20 Million Strategic Investment from Celgene Corporation |
| 09/12/2007 |
Vital Therapies, Inc. Raises $28.1 Million in Series C Financing |
| 09/11/2007 |
Phenomix Initiates Phase 2b Clinical Trial of Phx1149 for Type 2 Diabetes; Will Present Phx1149 Data At EASD |
| 08/20/2007 |
NeurAxon, Inc. Raises $32 Million in Series B Financing |
| 08/15/2007 |
The Multiple Myeloma Research Consortium (MMRC) And Proteolix, Inc. Initiate Phase 2 Clinical Trial |
| 08/02/2007 |
SunGard, Inc. Acquires VeriCenter Inc. |
| 07/10/2007 |
Aragon Surgical LapCap Receives FDA 510(k) Clearance With Expanded Indications for Use |
| 06/28/2007 |
Paracor Medical, Inc. Raises $44 Million in Series D Financing |
| 06/04/2007 |
Amgen Inc. Announces Aquisition of Ilypsa, Inc. |
| 05/10/2007 |
NeuroVista, Corp. Raises $33.8 Million in Series B Financing |
| 03/02/2007 |
Aragon Surgical, Inc. Acquires Verisure, Inc. |
| 02/26/2007 |
Cytyc to Acquire Adiana, Inc. |
| 02/08/2007 |
ProActa, Inc. Raises $35 Million in Series B Financing |
| 01/29/2007 |
Innerpulse, Inc. Raises $50 Million in New Equity Financing |
| 01/08/2007 |
PTC Therapeutics, Inc. Announces Strategic Drug Discovery Collaboration with Pfizer Corp. |
| 01/04/2007 |
Boston Scientific Acquires EndoTex Interventional Systems, Inc. |
| 01/01/2007 |
Phenomix Corp. Raises $55 Million in Series C Financing |
| 11/09/2006 |
Thermage, Inc. Announces Pricing of Initial Public Offering |
| 07/14/2006 |
Cordis Corporation Acquires Ensure Medical, Inc. |
| 06/29/2006 |
Daniel A. Pelak Appointed as President and Chief Executive Officer of Interventional Rhythym Management, Inc. |
| 06/06/2006 |
Alexza Initiates AZ-001 Phase IIb Clinical Trial in Patients with Migraine Headaches |
| 06/05/2006 |
Seattle Genetics Reports Encouraging SGN-40 Clinical Data at the American Society of Clinical Oncology Annual Meeting |
| 05/31/2006 |
Proteolix Closes $45 Million Financing |
| 05/25/2006 |
Antipodean Pharmaceuticals Initiates Phase 2 Trial in Parkinson's Disease |
| 05/12/2006 |
Cephalon Announces Acquisition of Salmedix |
| 05/03/2006 |
VC Deals: Drug maker's 2nd round brings in 35 million |
| 04/27/2006 |
Ilypsa and Astellas Enter a Licensing Agreement on ILY101 for Treatment of Hyperphosphatemia in Japan |
| 04/20/2006 |
Alexza Initiates AZ-002 Phase IIa Clinical Trial in Patients with Panic Disorder |
| 04/20/2006 |
Ilypsa Completes Phase 1 Clinical Trial of ILY101 for Hyperphosphatemia Associated with Chronic Kidney Disease |
| 04/06/2006 |
Thermage® Introduces New Eye Area Procedure at the American Society for Laser Medicine and Surgery Meeting in Boston |
| 03/30/2006 |
MicroVention and Terumo Corporation Announce Completion of Merger |
| 03/20/2006 |
Schering-Plough and PTC Therapeutics Announce Collaboration for Development of PTC's Preclinical Hepatitis C Compounds |
| 03/08/2006 |
Alexza Pharmaceuticals, Inc. Sets Price for Initial Public Offering |
| 02/14/2006 |
Delphi Partner Climbs The Midas List |
| 01/09/2006 |
KAI Pharmaceuticals, Inc. and Sankyo Company, Limited Enter Global Alliance to Develop and Commercialize Novel Compounds for Cardiovascular Disease |
| 05/09/2005 |
Adiana, Inc. Reports Completion of Treatment Phase of EASE Transcervical Sterilization Trial |
| 04/18/2005 |
Boston Scientific Announces Acquisition of TriVascular, Inc. |
| 04/13/2005 |
EndoTex Interventional Systems Announces European Approval of Novel Carotid Stent Delivery System |
| 07/27/2004 |
Novasys Medical Receives Additional Financing From Ascension Health Ventures |
| 07/22/2004 |
NeuroMetrix, Inc Announces Pricing of Initial Public Offering |
| 07/16/2004 |
Xenogen Corporation Announces Initial Public Offering |
| 07/01/2004 |
Bard Acquires Hernia Repair Fixation System |
| 06/22/2004 |
Thermage® Receives FDA Clearance for Full Face Treatment |
| 05/24/2004 |
Evalve, Inc. Announces Completion of a $35 Million Series C Financing |
| 04/28/2004 |
Novasys Medical Secures $25 Million in Series C Financing for Commercialization of a New Non-Surgical Treatment for Female Stress Urinary Incontinence |
| 03/25/2004 |
Boston Scientific and Endotex Interventional Systems, Inc. Announce Completion of Enrollment in Carotid Stenting Trial |
| 03/24/2004 |
NEUROMetrix Raises $10 Million in Additional Venture Financing |
| 02/20/2004 |
Boston Scientific Announces Investment in and Strategic Alliance with Cameron Health |
| 01/13/2004 |
Abbott Laboratories to Acquire Therasense |
| 12/03/2003 |
KAI Pharmaceuticals Receives $17 Million in Series A Round of Financing |
| 11/04/2003 |
Labcyte Joins Forces with Picoliter |
| 09/26/2003 |
Abbott Announces Acquisition of Integrated Vascular Systems, Inc. |
| 07/07/2003 |
Delphi Ventures Expands Investment Team |
| 05/19/2003 |
Boston Scientific Enters Into Definitive Agreement With EndoTex(TM) Interventional Systems, Inc. |
| 01/14/2003 |
Boston Scientific and TriVascular, Inc. Announce Strategic Alliance |
| 10/09/2002 |
AdvancePCS to Acquire Accordant Health Services; Unique Offering for High-Cost Case Management Complements AdvancePCS SpecialtyRx Capabilities |
| 02/14/2002 |
Smith & Nephew Reaches Agreement to Acquire ORATEC |
| 01/28/2002 |
Synaptics Raises $55 Million in IPO |
| 10/17/2001 |
TheraSense, Inc. Announces Exercise of Over-Allotment Option for Initial Public Offering |
| 10/11/2001 |
TheraSense Raises $114M In IPO |
| 08/07/2001 |
Omnicell IPO Gains 29% Debuts At $7 Per Share |
| 08/06/2001 |
MicroVention Raises $12.5 Million in Late-Stage Financing |
| 07/20/2001 |
Natus Medical Announces Initial Public Offering |
| 07/03/2001 |
TheraSense, Inc. Files for Initial Public Offering |
| 06/25/2001 |
Dennis Bonilla Joins MedSN as President & CEO |
| 06/14/2001 |
TriZetto Raises $55.5M in Secondary Offering |
| 02/15/2001 |
Boston Scientific Corporation Announces Agreement to Acquire Interventional Technologies, Inc. |
| |
Archived Press Releases |
